Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus

NCT01798238 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MP-513
DRUG: Placebo

Sponsor

Handok Inc.